LEADER 01688oam  2200433 a 450 
001 9910698589103321
005 20230902162240.0
035   $a(CKB)4950000000062805
035   $a(OCoLC)635577699
035   $a(EXLCZ)994950000000062805
100   $a20100601d2010      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiologics and biosimilars$b[electronic resource] $ebalancing incentives for innovation : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, July 14, 2009
210  1$aWashington :$cU.S. G.P.O.,$d2010.
215   $a1 online resource (iv, 252 pages) $cillustrations
300   $aTitle from title screen (viewed on June 1, 2010).
300   $a"Serial no. 111-73."
320   $aIncludes bibliographical references.
517   $aBiologics and biosimilars 
606   $aDrug development$xGovernment policy$zUnited States
606   $aPharmaceutical biotechnology$xGovernment policy$zUnited States
606   $aPharmaceutical biotechnology$zUnited States$vPatents
606   $aBiologicals$xGovernment policy$zUnited States
615  0$aDrug development$xGovernment policy
615  0$aPharmaceutical biotechnology$xGovernment policy
615  0$aPharmaceutical biotechnology
615  0$aBiologicals$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bAZL
801  2$bGPO
906   $aBOOK
912   $a9910698589103321
996   $aBiologics and biosimilars$93471818
997   $aUNINA